Targeting inflammation-induced transcription factor activation: an open frontier for glioma therapy.
about
Host mediated inflammatory influence on glioblastoma multiforme recurrence following high-dose ionizing radiation.Dehydrocostus lactone, a natural sesquiterpene lactone, suppresses the biological characteristics of glioma, through inhibition of the NF-κB/COX-2 signaling pathway by targeting IKKβ.Photoaffinity labeling of transcription factors by DNA-templated crosslinking.Tumor necrosis factor α-induced hypoxia-inducible factor 1α-β-catenin axis regulates major histocompatibility complex class I gene activation through chromatin remodeling.PPARγ regulated CIDEA affects pro-apoptotic responses in glioblastoma.Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy.Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression.Astrocytic growth through the autocrine/paracrine production of IL-1β in the early infectious phase of fowl glioma-inducing virus.FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells.TNFα regulates the localization of CD40 in lipid rafts of glioma cells.Immunoexcitatory mechanisms in glioma proliferation, invasion and occasional metastasis.Solasonine inhibits glioma growth through anti-inflammatory pathways.The role of sphingosine kinase isoforms and receptors S1P1, S1P2, S1P3, and S1P5 in primary, secondary, and recurrent glioblastomas.Oncrasin targets the JNK-NF-κB axis to sensitize glioma cells to TNFα-induced apoptosis.
P2860
Q33713130-AB7E6601-0D41-40BF-A550-D675D86B0015Q33850038-CEDDC7C4-453D-4BE0-AB7A-918286FCC354Q33863591-F995ED11-09C8-4AF7-8E0F-C47F84A6BB3EQ36978377-176DD906-BEE1-4339-92EF-1375EBA1323DQ37164423-2F97F2FE-32B7-409D-BACA-65C3B7929C7BQ38624686-3375FBC5-146E-42D6-88CA-3CD35ECE7EDFQ38637324-9A9AF5C9-A838-4CD1-B531-7B7666D88757Q38966633-FA929D0D-03AC-4275-A088-3BFE4E3BE451Q39276818-23335B6F-62B9-418F-997B-42E0AE783617Q39331132-B8162BD9-6E94-42F7-803D-60EDE93EAF72Q41541275-111AB7D2-7557-4428-8267-3F0D54DC8C26Q41865517-0EB6C634-01DB-4113-9BDE-4F863822EC90Q45048548-378E6CAD-80ED-4157-902F-15A26854B9B6Q48308236-30D8CFAE-E203-470E-A880-48BBB3804D60
P2860
Targeting inflammation-induced transcription factor activation: an open frontier for glioma therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Targeting inflammation-induced ...... n frontier for glioma therapy.
@en
Targeting inflammation-induced ...... n frontier for glioma therapy.
@nl
type
label
Targeting inflammation-induced ...... n frontier for glioma therapy.
@en
Targeting inflammation-induced ...... n frontier for glioma therapy.
@nl
prefLabel
Targeting inflammation-induced ...... n frontier for glioma therapy.
@en
Targeting inflammation-induced ...... n frontier for glioma therapy.
@nl
P1433
P1476
Targeting inflammation-induced ...... en frontier for glioma therapy
@en
P2093
Ellora Sen
P304
P356
10.1016/J.DRUDIS.2011.09.003
P50
P577
2011-09-06T00:00:00Z